EP3128997
BINDISAMEINDIR SEM ERU SÉRTÆKAR FYRIR IL-21 OG NOTKUN ÞEIRRA
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.4.2015EP published:
5.8.2020EP application number:
15776002.6
EP translation filed:
31.8.2020Grant published:
15.10.2020EPO information:
European Patent Register
Max expiry date:
6.4.2035Expiry date:
6.4.2025
Title:
BINDING MOLECULES SPECIFIC FOR IL-21 AND USES THEREOF
Timeline
Today
7.4.2015EP application
5.8.2020EP Publication
31.8.2020Translation submitted
15.10.2020Registration published
6.4.2025Expires
Owner
Name:
Boston Pharmaceuticals Inc.Address:
55 Cambridge Parkway, Suite 400, Cambridge MA 02142, US
Inventor
Name:
ETTINGER, CatherineAddress:
Gaithersburg, MD 20878, US
Name:
KARNELL, JodiAddress:
Gaithersburg, MD 20878, US
Name:
DAMSCHRODER, MelissaAddress:
Gaithersburg, MD 20878, US
Name:
CHOWDHURY, ParthaAddress:
Gaithersburg, MD 20878, US
Name:
XIAO, XiaodongAddress:
Gaithersburg, MD 20878, US
Name:
TSUI, PingAddress:
Gaithersburg, MD 20878, US
Name:
VARKEY, ReenaAddress:
Gaithersburg, MD 20878, US
Name:
DRABIC, StaceyAddress:
Gaithersburg, MD 20878, US
Name:
CARTER, LauraAddress:
Ann Arbor, MI 48105, US
Name:
HERBST, RonaldAddress:
Gaithersburg, MD 20878, US
Name:
DU, QunAddress:
Gaithersburg, MD 20878, US
Name:
NAIMAN, Brian, MichaelAddress:
Gaithersburg, MD 20878, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201461976684 PDate:
8.4.2014Country:
US
Classification
Categories:
A61K 8/64, C07K 16/42
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 29.3.2021
Expires: 6.4.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.3.2022
Expires: 6.4.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 26.3.2023
Expires: 6.4.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 26.3.2024
Expires: 6.4.2025
Payer: Árnason Faktor ehf.